ASH 2016 Page 4 Update on Antibody Therapies in Indolent Non-Hodgkin Lymphoma
Author: cancergrace Added: 06/28/2019 (Source: Oncology Tube)
Source: Oncology Tube - June 28, 2019 Category: Cancer & Oncology Source Type: podcasts

CLL and Non-Hodgkin Lymphoma, What new drugs are on the horizon and why are they exciting
Author: cancergrace Added: 06/26/2019 (Source: Oncology Tube)
Source: Oncology Tube - June 27, 2019 Category: Cancer & Oncology Source Type: podcasts

CLL and Non-Hodgkin Lymphoma, What are the risks and benefits of both ibrutinib and Idelalisib
CLL and non-hodgkin lymphoma, What are the risks and benefits of both ibrutinib and Idelalisib Author: cancergrace Added: 06/26/2019 (Source: Oncology Tube)
Source: Oncology Tube - June 27, 2019 Category: Cancer & Oncology Source Type: podcasts

Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma, Should all HL patients be treated the same
Chronic Lymphocytic Leukemia Non-Hodgkin Lymphoma Should all HL patients be treated the same Author: cancergrace Added: 06/26/2019 (Source: Oncology Tube)
Source: Oncology Tube - June 27, 2019 Category: Cancer & Oncology Source Type: podcasts

Non-hodgkin lymphoma advances in 2018
Steven Rosen, MD, from the City of Hope, Duarte, CA, discusses the remarkable quantity and quality of information on blood cancer therapeutics that has been collected and presented at the Internationa... Author: VJHemOnc Added: 10/04/2018 (Source: Oncology Tube)
Source: Oncology Tube - October 4, 2018 Category: Cancer & Oncology Source Type: podcasts

Nuances of systemic lymphoma and CNS lymphoma
Speaking from the International Workshop on Non-Hodgkin Lymphoma (iwNHL) 2018 meeting, held in Nice, France, Bianca Santomasso, MD, PhD, of Memorial Sloan Kettering Cancer Center, NY, discusses how so... Author: VJHemOnc Added: 10/04/2018 (Source: Oncology Tube)
Source: Oncology Tube - October 4, 2018 Category: Cancer & Oncology Source Type: podcasts

CD47-targeting antibody: targeting the source of non-Hodgkin lymphoma
CD47 has been found to be present on leukemic stem cells, but not on normal hematopoietic stem cells, offering an opportunity to target the source of the disease. Here, Irving Weissman, MD, of the Sta... Author: VJHemOnc Added: 10/02/2018 (Source: Oncology Tube)
Source: Oncology Tube - October 2, 2018 Category: Cancer & Oncology Source Type: podcasts

Pathobiology and clinical management of T-cell lymphoma
From the International Workshop on Non-Hodgkin Lymphoma (iwNHL) 2018 meeting held in Nice, France, Francine Foss, MD, of Yale University School of Medicine, New Haven, CT, discusses the pathology and... Author: VJHemOnc Added: 10/01/2018 (Source: Oncology Tube)
Source: Oncology Tube - October 1, 2018 Category: Cancer & Oncology Source Type: podcasts

Are biomarkers the future in Non-Hodgkin Lymphoma?
Speaking at the 2018 Society of Hematologic Oncology (SOHO) Annual Meeting in Houston, TX, Nathan Fowler, MD, of The University of Texas MD Anderson Cancer Center, Houston, TX, discusses the increasin... Author: VJHemOnc Added: 09/19/2018 (Source: Oncology Tube)
Source: Oncology Tube - September 19, 2018 Category: Cancer & Oncology Source Type: podcasts

John P. Leonard, MD - The Arrival of Novel Agent Classes in B-Cell Non-Hodgkin Lymphoma: A Personal Guide to Integrating New Therapy Into Patient Care
The Arrival of Novel Agent Classes in B-Cell Non-Hodgkin Lymphoma: A Personal Guide to Integrating New Therapy Into Patient Care (Source: PeerView CME/CE Audio Podcast - Pulmonology)
Source: PeerView CME/CE Audio Podcast - Pulmonology - July 9, 2018 Category: Respiratory Medicine Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: podcasts

Long-term follow-up results of the ZUMA-1 trial of anti-CD19 CAR T-cells for non-Hodgkin lymphoma
The latest CAR T-cell data was highly anticipated at the American Society of Hematology (ASH) 2017 Annual Meeting and Exposition in Atlanta, GA. Speaking from the meeting, Sattva Neelapu, MD, from the... Author: VJHemOnc Added: 01/05/2018 (Source: Oncology Tube)
Source: Oncology Tube - January 5, 2018 Category: Cancer & Oncology Source Type: podcasts

Lymphoma Research and Treatment Update From ASH 2017
Whats the latest news coming out for Hodgkin lymphoma treatment and non-Hodgkin lymphoma treatment? Dr. Andrew Evens at Northwestern Medicine gives us an update from the American Society of Clinical ... Author: patientpower Added: 12/21/2017 (Source: Oncology Tube)
Source: Oncology Tube - December 22, 2017 Category: Cancer & Oncology Source Type: podcasts

Making cancer treatments more affordable
Steven T. Rosen, MD, from the City of Hope, Duarte, CA, discusses the affordability of cancer treatments at the 2017 International Workshop in Non-Hodgkin Lymphoma (iwNHL) in Vancouver, BC, Canada. Th... Author: VJHemOnc Added: 11/21/2017 (Source: Oncology Tube)
Source: Oncology Tube - November 21, 2017 Category: Cancer & Oncology Source Type: podcasts

Repurposed HIV and arthritis drugs in the treatment of leukaemia
Steven T. Rosen, MD, from the City of Hope, Duarte, CA, discusses novel conceptual treatment approaches at the 2017 International Workshop in Non-Hodgkin Lymphoma (iwNHL) in Vancouver, BC, Canada. A n... Author: VJHemOnc Added: 11/21/2017 (Source: Oncology Tube)
Source: Oncology Tube - November 21, 2017 Category: Cancer & Oncology Source Type: podcasts

The evolution of CAR T-cell therapy
Steven T. Rosen, MD, from the City of Hope, Duarte, CA, discusses the evolution of CAR T-cell therapy at the 2017 International Workshop in Non-Hodgkin Lymphoma (iwNHL) in Vancouver, BC, Canada. CAR T... Author: VJHemOnc Added: 11/21/2017 (Source: Oncology Tube)
Source: Oncology Tube - November 21, 2017 Category: Cancer & Oncology Source Type: podcasts

BTK inhibitors: toxicity, resistance, and combinations
Steven T. Rosen, MD, from the City of Hope, Duarte, CA, discusses recent developments in BTK inhibitors at the 2017 International Workshop in Non-Hodgkin Lymphoma (iwNHL) in Vancouver, BC, Canada. BTK... Author: VJHemOnc Added: 11/21/2017 (Source: Oncology Tube)
Source: Oncology Tube - November 21, 2017 Category: Cancer & Oncology Source Type: podcasts

Exciting advances in checkpoint inhibitors CAR T-cells, and ALK inhibitors
Steven T. Rosen, MD, from the City of Hope, Duarte, CA, discusses highlights of the 2017 International Workshop in Non-Hodgkin Lymphoma (iwNHL) in Vancouver, BC, Canada. More concrete data had been re... Author: VJHemOnc Added: 11/20/2017 (Source: Oncology Tube)
Source: Oncology Tube - November 20, 2017 Category: Cancer & Oncology Source Type: podcasts

Side effects of novel PI3K inhibitors
Nathan Fowler, MD, from the University of Texas MD Anderson Cancer Center, Houston, TX, discusses side effects of PI3K inhibitors at the 2017 International Workshop in Non-Hodgkin Lymphoma (iwNHL) in ... Author: VJHemOnc Added: 11/17/2017 (Source: Oncology Tube)
Source: Oncology Tube - November 17, 2017 Category: Cancer & Oncology Source Type: podcasts

iwNHL 2017 highlights: the PDX model
Marek Trneny, MD, from the Charles University, Prague, Czech Republic, discusses highlights from the International Workshop on Non-Hodgkin Lymphoma (iwNHL) 2017, held in Vancouver, BC, Canada. The PDX... Author: VJHemOnc Added: 11/17/2017 (Source: Oncology Tube)
Source: Oncology Tube - November 17, 2017 Category: Cancer & Oncology Source Type: podcasts

CC122: a new IMiD in the treatment of diffuse large B-cell lymphoma
John Kuruvilla, MD, FRCPC, from the Princess Margaret Cancer Centre, Toronto, Canada, discusses the development of IMiDs at the International Workshop on Non-Hodgkin Lymphoma (iwNHL) 2017, held in Van... Author: VJHemOnc Added: 11/17/2017 (Source: Oncology Tube)
Source: Oncology Tube - November 17, 2017 Category: Cancer & Oncology Source Type: podcasts

Targeting chemokines in lymphoma
Francine Foss, MD, from the Yale University School of Medicine, New Haven, CT, discusses targeting chemokines at the International Workshop on Non-Hodgkin Lymphoma (iwNHL) 2017 meeting, held in Vancou... Author: VJHemOnc Added: 11/16/2017 (Source: Oncology Tube)
Source: Oncology Tube - November 16, 2017 Category: Cancer & Oncology Source Type: podcasts

Do CAR T-Cell therapies look promising for the treatment of NHL?
Jeff Sharman, MD of Willamette Valley Cancer Center discusses whether or not CAR T-cell therapy is promising for the treatment of non-hodgkin lymphoma. This was recorded at the 2017 ASCO Annual Meetin... Author: obr Added: 06/22/2017 (Source: Oncology Tube)
Source: Oncology Tube - June 23, 2017 Category: Cancer & Oncology Source Type: podcasts

Results of the MAGNIFY study for high-risk indolent non-hodgkin lymphoma patients
Kathryn Kolibaba, MD of US Oncology Research discusses the MAGNIFY study and its impact on high-risk indolent NHL patients at the 2017 ASCO Annual Meeting in Chicago, IL. Author: obr Added: 06/21/2017 (Source: Oncology Tube)
Source: Oncology Tube - June 21, 2017 Category: Cancer & Oncology Source Type: podcasts

Results of BRIGHT study in front line indolent non-hodgkin lymphoma patients
Kathryn Kolibaba, MD of US Oncology Research gives an overview of the results from the BRIGHT study and its impact on treatment for indolent non-hodgkin lymphoma patients. This was recorded at the 201... Author: obr Added: 06/21/2017 (Source: Oncology Tube)
Source: Oncology Tube - June 21, 2017 Category: Cancer & Oncology Source Type: podcasts

Keeping Family in Mind: A Cancer Survivors Advice for Experts
As part of our coverage of the 2017 ASCO Survivorship Symposium, non-Hodgkin lymphoma survivor, Lou Lanza, talks about his hope for the future and advice he shared with his medical team.Get email ... Author: patientpower Added: 02/22/2017 (Source: Oncology Tube)
Source: Oncology Tube - February 23, 2017 Category: Cancer & Oncology Source Type: podcasts

Update on Antibody Therapies in Indolent Non-Hodgkin Lymphoma
GRACE is pleased to present a series of webcasts with faculty member John Pagel, MD, PhD, DSc, from Swedish Cancer Institute. Dr. Pagel was one of many to attend the American Society of Hematologys A... Author: cancergrace Added: 01/17/2017 (Source: Oncology Tube)
Source: Oncology Tube - January 18, 2017 Category: Cancer & Oncology Source Type: podcasts

Aboriginal way of life and cancer diagnosis
Roslyn Weetra, an Aboriginal Elder and cancer survivor, discusses her experience with cancer being a member of the Australian aboriginal community. She was diagnosed with non-Hodgkins lymphoma and re... Author: VJOncology Added: 12/09/2016 (Source: Oncology Tube)
Source: Oncology Tube - December 9, 2016 Category: Cancer & Oncology Source Type: podcasts

CLL and Non Hodgkin Lymphoma: What new drugs are on the horizon and why are they exciting?
John Kuruvilla, MD, Associate Professor, Princess Margaret Hospital, University Health Network in Toronto, Canada, spoke with GRACE about Chronic Lymphocytic Leukemia (CLL) and Non Hodgkin Lymphoma, ... Author: cancergrace Added: 09/13/2016 (Source: Oncology Tube)
Source: Oncology Tube - September 13, 2016 Category: Cancer & Oncology Source Type: podcasts

TGR-1202 in CLL and Non-Hodgkin lymphoma
Howard Burris, MD from Sarah Cannon, Nashville, TN discusses TGR-1202 for chronic lymphocytic leukemia (CLL) and Non-Hodgkin lymphoma (NHL). TGR-1202 is a PI3K delta inhibitor and Dr Burris discusses ... Author: VJHemOnc Added: 07/05/2016 (Source: Oncology Tube)
Source: Oncology Tube - July 5, 2016 Category: Cancer & Oncology Source Type: podcasts

iwNHL 2015: Emerging monoclonal antibodies for lymphoma therapy
At the International Workshop on Non-Hodgkin Lymphoma (iwNHL) 2015 meeting, Thomas J. Kipps, MD, PhD, of the University of California, San Diego, San Diego, CA, discusses novel monoclonal antibodies a... Author: VJHemOnc Added: 11/22/2015 (Source: Oncology Tube)
Source: Oncology Tube - November 23, 2015 Category: Cancer & Oncology Source Type: podcasts

iwNHL 2015: Approaches to overcome side effects of idelalisib for follicular lymphoma
At the International Workshop on Non-Hodgkin Lymphoma (iwNHL) 2015 meeting, John Gribben, MD, DSc, FRCPath, FRCP FMedSci, of Barts and The London School of Medicine and Dentistry, London, UK, discusse... Author: VJHemOnc Added: 11/22/2015 (Source: Oncology Tube)
Source: Oncology Tube - November 23, 2015 Category: Cancer & Oncology Source Type: podcasts

iwNHL 2015: Combination studies with venetoclax (ABT-199), BCL-2 inhibitor, for non-Hodgkin lymphoma
At the International Workshop on Non-Hodgkin Lymphoma (iwNHL) 2015 meeting, Michael E. Williams, MD, of the University of Virginia School of Medicine, Charlottesville, VA, discusses the clinical devel... Author: VJHemOnc Added: 11/22/2015 (Source: Oncology Tube)
Source: Oncology Tube - November 23, 2015 Category: Cancer & Oncology Source Type: podcasts

iwNHL 2015: Determining effective combinations of immune checkpoint inhibitors for lymphoma
At the International Workshop on Non-Hodgkin Lymphoma (iwNHL) 2015 meeting, Stephen M. Ansell, MD, PhD, of Mayo Clinic, Rochester, MN, discusses the clinical development of combination approaches with... Author: VJHemOnc Added: 11/22/2015 (Source: Oncology Tube)
Source: Oncology Tube - November 23, 2015 Category: Cancer & Oncology Source Type: podcasts

iwNHL 2015: Duvelisib, dual inhibitor of PI3K delta and PI3K gamma, for indolent non-Hodgkin lymphoma
At the International Workshop on Non-Hodgkin Lymphoma (iwNHL) 2015 meeting, Ian Flinn, MD, of Tennessee Oncology, Nashville, TN, discusses the clinical development of duvelisib, a dual inhibitor of ph... Author: VJHemOnc Added: 11/22/2015 (Source: Oncology Tube)
Source: Oncology Tube - November 23, 2015 Category: Cancer & Oncology Source Type: podcasts

iwNHL 2015: Ibrutinib, Bruton’s tyrosine kinase inhibitor, for non-Hodgkin lymphoma
At the International Workshop on Non-Hodgkin Lymphoma (iwNHL) 2015 meeting, Thomas J. Kipps, MD, PhD, of the University of California, San Diego, San Diego, CA, discusses the currently available data ... Author: VJHemOnc Added: 11/22/2015 (Source: Oncology Tube)
Source: Oncology Tube - November 23, 2015 Category: Cancer & Oncology Source Type: podcasts

iwNHL 2015: Monoclonal antibody therapies for cutaneous T-cell lymphoma
At the International Workshop on Non-Hodgkin Lymphoma (iwNHL) 2015 meeting, Pier Luigi Zinzani, MD, PhD, of University of Bologna, Bologna, Italy, discusses the clinical development of the anti-CD30 a... Author: VJHemOnc Added: 11/22/2015 (Source: Oncology Tube)
Source: Oncology Tube - November 23, 2015 Category: Cancer & Oncology Source Type: podcasts

iwNHL 2015: Selinexor, selective inhibitor of nuclear export, for non-Hodgkin lymphoma
At the International Workshop on Non-Hodgkin Lymphoma (iwNHL) 2015 meeting, John Kuruvilla, MD, of Princess Margaret Cancer Centre, Toronto, Canada, discusses the early clinical activity of selinexor,... Author: VJHemOnc Added: 11/22/2015 (Source: Oncology Tube)
Source: Oncology Tube - November 23, 2015 Category: Cancer & Oncology Source Type: podcasts

iwNHL 2015: TGR-1202, novel PI3K delta inhibitor, for hematological malignancies
At the International Workshop on Non-Hodgkin Lymphoma (iwNHL) 2015 meeting, Owen A. O'Connor, MD, PhD, of Columbia University, New York, NY, discusses TGR-1202, a novel phosphoinositide 3-kinase (PI3K... Author: VJHemOnc Added: 11/22/2015 (Source: Oncology Tube)
Source: Oncology Tube - November 23, 2015 Category: Cancer & Oncology Source Type: podcasts

iwNHL 2015: Therapeutic opportunities for lenalidomide in non-Hodgkin lymphoma
At the International Workshop on Non-Hodgkin Lymphoma (iwNHL) 2015 meeting, Nathan H. Fowler, MD, of The University of Texas MD Anderson Cancer Center, Houston, TX, discusses the ongoing clinical tria... Author: VJHemOnc Added: 11/22/2015 (Source: Oncology Tube)
Source: Oncology Tube - November 23, 2015 Category: Cancer & Oncology Source Type: podcasts

iwNHL 2015: Biology of diffuse large B-cell lymphoma
At the International Workshop on Non-Hodgkin Lymphoma (iwNHL) 2015 meeting, Catherine M. Bollard, MBChB, MD, FRACP, FRCPA, of Children's National Health System and The George Washington University, Wa... Author: VJHemOnc Added: 11/22/2015 (Source: Oncology Tube)
Source: Oncology Tube - November 23, 2015 Category: Cancer & Oncology Source Type: podcasts

iwNHL 2015: Future directions for the management of non-Hodgkin lymphoma
At the International Workshop on Non-Hodgkin Lymphoma (iwNHL) 2015 meeting, Anas Younes, MD, of Memorial Sloan Kettering Cancer Center, New York, NY, chairs a discussion with Steven T. Rosen, MD, of C... Author: VJHemOnc Added: 11/20/2015 (Source: Oncology Tube)
Source: Oncology Tube - November 20, 2015 Category: Cancer & Oncology Source Type: podcasts

iwNHL 2015: Immune checkpoint blockade for non-Hodgkin lymphoma
At the International Workshop on Non-Hodgkin Lymphoma (iwNHL) 2015 meeting, John Gribben, MD, DSc, FRCPath, FRCP FMedSci, of Barts and The London School of Medicine and Dentistry, London, UK, chairs a... Author: VJHemOnc Added: 11/20/2015 (Source: Oncology Tube)
Source: Oncology Tube - November 20, 2015 Category: Cancer & Oncology Source Type: podcasts

iwNHL 2015: Improving treatment strategies for T-cell lymphoma
At the International Workshop on Non-Hodgkin Lymphoma (iwNHL) 2015 meeting, Francine M. Foss, MD, of the Yale University School of Medicine, New Haven, CT, chairs a discussion with Laurence de Leval, ... Author: VJHemOnc Added: 11/20/2015 (Source: Oncology Tube)
Source: Oncology Tube - November 20, 2015 Category: Cancer & Oncology Source Type: podcasts

iwNHL 2015: Molecular biology of T-cell lymphoma
At the International Workshop on Non-Hodgkin Lymphoma (iwNHL) 2015 meeting, Francine M. Foss, MD, of the Yale University School of Medicine, New Haven, CT, chairs a discussion with Laurence de Leval, ... Author: VJHemOnc Added: 11/20/2015 (Source: Oncology Tube)
Source: Oncology Tube - November 20, 2015 Category: Cancer & Oncology Source Type: podcasts

iwNHL 2015: Novel therapeutic combinations for relapsed/refractory T-cell lymphoma
At the International Workshop on Non-Hodgkin Lymphoma (iwNHL) 2015 meeting, Francine M. Foss, MD, of the Yale University School of Medicine, New Haven, CT, chairs a discussion with Laurence de Leval, ... Author: VJHemOnc Added: 11/19/2015 (Source: Oncology Tube)
Source: Oncology Tube - November 19, 2015 Category: Cancer & Oncology Source Type: podcasts